Lorlatinib Impurity 26 | CAS 1454849-99-0 - Request Quote
Lorlatinib Impurity 26
| SZ CAT No: | SZ-L054035 |
| CAS No | 1454849-99-0 |
| Mol.F. | C7H10N4 |
| Mol.Wt. | 150.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lorlatinib Impurity 26 is chemically 1-Methyl-5-((methylamino)methyl)-1H-pyrazole-3-carbonitrile. Lorlatinib Impurity 26 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 26 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1454849-99-0
Purchase 1454849-99-0
Order 1454849-99-0
Enquire 1454849-99-0
price of 1454849-99-0
1454849-99-0 Supplier
1454849-99-0 Manufacturer
1454849-99-0 Exporter
buy high quality Lorlatinib Impurity 26
Purchase Lorlatinib Impurity 26
Lorlatinib Impurity 26 suppliers
Lorlatinib Impurity 26 manufacturers
Lorlatinib Impurity 26 price
Order Lorlatinib Impurity 26
Enquire Lorlatinib Impurity 26
Lorlatinib Impurity 26 cost
Lorlatinib Impurity 26 Supplier
Lorlatinib Impurity 26 Distributor
Lorlatinib Impurity 26 for Method Validation
Lorlatinib Reference Standard
Lorlatinib Impurity 26 for ANDA Filing
Lorlatinib Impurity 26 for Forced Degradation Studies
Lorlatinib Impurity 26 Identification Standards
Lorlatinib Impurity 26 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


